These data provide insight into the role of Drak2 in autoimmune diseases by showing that Drak2 may not suppress TGF-β signaling in T cells, and therefore may contribute to autoimmune disease via other molecular pathways. This evidence concerns the gene STK17B and autoimmune disease.